Seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.
Increasing the value of Ontario’s best oncology innovations and attracting investment from the private sector (current as of November 2021).
In total funding and equity investments
In additional financing attracted
Ontario start-ups created
Our investments are at the forefront of Ontario’s biotech ecosystem.
Our investments bridge the life sciences seed funding gap.
Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.
Keep up to date on our investments and business developments in recent news stories and summaries.
April 28, 2022 – Early-stage capital positions science and intellectual property for Ontario economic impact April 27, 2022 – FACIT announced two recent strategic investments from its Prospects Oncology Fund in innovations arising from renowned cancer experts at the Ontario Institute for Cancer Research (OICR): Dr. Rima Al-awar, Head of Therapeutic Innovation and Drug Discovery, and Dr. Lincoln Stein, Head
February 4, 2022 – Annual event showcases emerging entrepreneurs and FACIT’s commitment to advance Ontario’s most promising oncology innovations February 4, 2022 – FACIT, a commercialization venture firm for Ontario cancer innovations, is pleased to announce the 2022 winner of its Falcons’ Fortunes pitch competition: Point Surgical Inc.. Point Surgical was founded as a joint venture between Toronto’s University Health
January 27, 2022 – January 27, 2022 – FACIT congratulates portfolio company Cellular Analytics on a recent publication by its CSO, Dr. Shana Kelley and collaborators, on the Company’s tumor-infiltrating lymphocyte (TIL) therapeutics platform.
We were established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. OICR conducts and enables world-class cancer research, filling a critical role as a pan-provincial connector of oncology researchers, resources and cancer innovation development. Together with OICR, we drive a shared vision to attract more R&D investment in Ontario and help the best oncology innovations reach the market and save lives.
FACIT is funded in part by the Government of Ontario through OICR